WA

Written & reviewed by WhatAreAllergies Editorial Team

Editorial Review

Health Editors & Medical Writers · Allergy, Immunology & Clinical Health Content

WhatAreAllergies.com

Updated May 2026·Annual review cycle

Our editorial process: All content on WhatAreAllergies.com is written and reviewed by our editorial team following published guidelines from ACAAI, AAAAI, WAO, and ARIA. Content is updated annually or when major guidelines change. This content is educational only — not a substitute for professional medical advice. We do not accept advertising influence on editorial content. Read our editorial policy →

Quick Answer

Eczema (atopic dermatitis) and psoriasis are both chronic inflammatory skin conditions but have distinct characteristics. Eczema is intensely itchy, begins in childhood, worsens with allergens and irritants, and appears in flexural creases. Psoriasis produces well-defined scaly plaques, is less itchy, appears on extensor surfaces, and is driven by T-cell autoimmunity rather than IgE allergy.

Appearance: How They Look Different

Atopic dermatitis (eczema) presents as erythematous (red), weeping, oozing patches with indistinct borders. In acute phases, vesicles (tiny blisters) and crusting are common. In chronic phases, skin becomes lichenified (thickened with visible skin markings), hyperpigmented, and leathery from chronic scratching. Eczema lesions have soft, irregular edges and a dull, matte appearance.

Psoriasis presents as well-demarcated, raised plaques covered with silvery-white scale — the scale results from accelerated keratinocyte turnover (cells renew every 3–5 days instead of the normal 28). Plaques have sharp, clearly defined borders and a shiny, reflective appearance when scale is present. The Auspitz sign — pinpoint bleeding on removal of scale — is characteristic of psoriasis.

FeatureEczema (Atopic Dermatitis)Psoriasis
AppearanceRed, weeping, ill-defined patchesThick, silvery-scaled plaques
LocationFlexural creases (elbow, knee)Extensor surfaces, scalp, nails
Itch severityIntense, distressingModerate, sometimes absent
Age of onsetUsually infancy–childhoodYoung adult to middle age
Trigger patternAllergens, irritants, S. aureusStress, infection, medications
IgE involvementYes — often elevatedNo — T-cell autoimmune

Location on the Body

Eczema characteristically affects flexural skin — the inner elbow crease, back of the knee, wrists, ankles, and neck — though in infants it often begins on the cheeks and scalp. Flexural distribution results from occlusion and friction in skin folds that worsen barrier damage and sweat retention.

Psoriasis classically affects extensor surfaces — the outer elbows, knees, and shins — as well as the scalp (often with distinct hairline involvement), lower back (sacrum), and nails (pitting, onycholysis, and oil spots are psoriatic nail changes). Inverse psoriasis affects skin folds (armpits, groin, under breasts) and lacks the silvery scale. Genital and nail involvement are more specific for psoriasis.

Causes and Immune Mechanisms

Eczema is part of the atopic march — it has strong IgE immune involvement, elevated total and specific IgE, skin barrier dysfunction (filaggrin deficiency), and Th2-dominant inflammation. It is frequently associated with asthma, allergic rhinitis, and food allergy in the same patient. Environmental allergens (dust mites, pets, pollen) and food allergens trigger flares.

Psoriasis is a T-cell-mediated autoimmune condition driven by Th1 and Th17 lymphocytes rather than Th2/IgE. Triggers include streptococcal infections (Koebner phenomenon), physical trauma, stress, certain medications (beta-blockers, lithium, NSAIDs, antimalarials), and alcohol use. Psoriasis has a strong genetic component (HLA-Cw6 is the strongest risk allele) and is associated with psoriatic arthritis, cardiovascular disease, and metabolic syndrome — conditions not associated with eczema.

Key Takeaways

  • Eczema: ill-defined itchy patches in flexural creases; psoriasis: sharply bordered scaly plaques on extensor surfaces.
  • Eczema is Th2/IgE-mediated (atopic); psoriasis is Th1/Th17 autoimmune (not IgE-related).
  • Psoriasis nails show pitting and onycholysis; eczema does not typically affect nails.
  • Eczema is associated with asthma and food allergy; psoriasis is associated with psoriatic arthritis and cardiovascular disease.
  • Both conditions can be difficult to distinguish in clinical practice — a dermatologist should diagnose uncertain cases.

Frequently Asked Questions

Can you have both eczema and psoriasis at the same time?
Yes, though it is uncommon. Both conditions can co-exist in the same patient. When they overlap, diagnosis and treatment become particularly complex. A dermatologist with experience in both conditions should evaluate patients with mixed features or treatment-refractory skin disease.
Is psoriasis an allergy?
No. Psoriasis is a chronic autoimmune condition driven by Th1 and Th17 lymphocytes attacking keratinocytes, not by IgE or allergen-specific immune responses. Psoriasis is not triggered by allergens, does not cause anaphylaxis, and is not treated with antihistamines or allergen immunotherapy. It requires anti-inflammatory or immunomodulatory treatments including topical steroids, phototherapy, and biologics.
Does diet affect eczema or psoriasis?
For eczema in young children, food allergy (milk, egg, peanut) can be a trigger in severe cases. For adults with eczema, food allergy is rarely a primary driver. For psoriasis, diet can influence severity — alcohol consumption worsens psoriasis significantly, and some evidence links obesity, gluten (in anti-gliadin antibody-positive patients), and nightshades with flare risk in susceptible individuals.

About the Medical Team

WA
Medical Review

WhatAreAllergies Editorial Team,

Health Editors & Medical Writers

Allergy, Immunology & Clinical Health Content

WhatAreAllergies.com
WA
Written by

WhatAreAllergies Editorial Team,

Health Content Editor

Clinical Allergy & Immunology Content

WhatAreAllergies.com

Content is written by our editorial team following current clinical guidelines from ACAAI, AAAAI, and WAO. Educational only — always consult a qualified healthcare provider for medical advice. View editorial policy →

Medical References & Citations

  1. 1
    guideline2006

    Sampson HA, et al. "Second symposium on the definition and management of anaphylaxis: Summary report" — Journal of Allergy and Clinical Immunology.

    View source
  2. 2
    database2025

    American College of Allergy, Asthma & Immunology (ACAAI) "Allergy Facts and Figures" — ACAAI Clinical Resources.

    View source
  3. 3
    review2025

    World Allergy Organization (WAO) "White Book on Allergy — 2025 Update" — World Allergy Organization.

    View source
  4. 4
    guideline2024

    National Institute of Allergy and Infectious Diseases (NIAID) "Clinical Guidelines for the Diagnosis and Management of Food Allergy" — National Institutes of Health.

    View source
  5. 5
    guideline2024

    Muraro A, et al. "EAACI food allergy and anaphylaxis guidelines: Diagnosis and management of food allergy" — Allergy — European Journal of Allergy and Clinical Immunology.

This content reflects clinical guidelines current as of the last review date shown above. Always consult a qualified healthcare provider for personalized medical advice.